Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The transcriptional adaptor 1 pseudogene (ENSG00000253571, LOC392180) is classified as a pseudogene, meaning it is a nonfunctional segment of DNA derived from the transcriptional adaptor 1 (TADA1) gene[1][8][10]. Pseudogenes are typically sequences that resemble protein-coding genes but have lost their coding potential due to mutations. While some pseudogenes have regulatory RNA activities, there is no specific evidence that this pseudogene is functional, disease-associated, or relevant as a therapeutic target[1][2][8][5]. It should not be confused with the functional "Transcriptional adaptor 1" (TADA1) gene or protein[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcriptional adaptor 1 pseudogene.